17 أغسطس #castration-resistant #Celecoxib #Docetaxel #Phase II #prostate cancer #trial #weekly #Zoledronic acid Phase II trial of weekly Docetaxel, Zoledronic acid, and Celecoxib for castration-resistant prostate cancer by Dr. Fadi Farhat 0
